Positive Airway Pressure in the Treatment of Sleep Apnea-Hypopnea

Sleep Disorders Medicine

Volumn , Issue , 2009, Pages 340-360

  Sanders, Mark H ^a   Strollo, Patrick J ^b,c   Atwood, Charles W ^a,c,d   Stiller, Ronald A ^c,e   O'Donnell, Christopher P ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882472048     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7506-7584-0.00025-2     Document Type: Chapter

References (242)

1. Sullivan C.E., Issa F.G., Berthon-Jones M., Eves L. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 1981, 1:862.
2. Sériès F., Cormier Y., Couture J., Desmeules M. Changes in upper airway resistance with lung inflation and positive airway pressure. J Appl Physiol 1990, 68:1075.
3. Sériès F., Cormier Y., Desmueles M. Influence of passive changes of lung volume on upper airways. J Appl Physiol 1990, 68:2159.
4. Begle R.L., Sadr S., Skatrud J.B., Dempsey J.A. Effect of lung inflation on pulmonary resistance during NREM sleep. Am Rev Respir Dis 1990, 141:854.
5. van de Graaf W.B. Thoracic influence on upper airway patency. J Appl Physiol 1988, 65:2124.
6. Heinzer R.C., Stanchina M.L., Malhotra A., et al. Lung volume and continuous positive airway pressure requirements in obstructive sleep apnea. Am J Respir Crit Care Med 2005, 172:114.
7. Sanders M.H. Nasal CPAP effect on patterns of sleep apnea. Chest 1984, 86:839.
8. Issa F.G., Sullivan C.E. Reversal of central sleep apnea using nasal CPAP. Chest 1986, 90:165.
9. Sanders M.H., Moore S.E. Inspiratory and expiratory partitioning of airway resistance during sleep in patients with sleep apnea. Am Rev Respir Dis 1983, 127:554.
10. Sanders M.H., Rogers R.M., Pennock B.E., et al. Prolonged expiratory phase in sleep apnea: a unifying hypothesis. Am Rev Respir Dis 1985, 131:401.
11. Younes M., Ostrowski M., Thompson W., et al. Chemical control stability in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2001, 163:1181.
12. Wellman A., Jordan A.S., Malhotra A., et al. Ventilatory control and airway anatomy in obstructive sleep apnea. Am J Respir Crit Care Med 2004, 170:1225.
13. 2 below eupnea as a determinent of ventilatory stability in sleep. J Physiol 2004, 560:1.
14. Khoo M.KC. Using loop gain to assess ventilatory control in obstructive sleep apnea. Am J Respir Crit Care Med 2001, 163:1044.
15. Smith P.L., Wise R.A., Gold A.R., et al. Upper airway pressure-flow relationships in obstructive sleep apnea. J Appl Physiol 1988, 64:789.
16. Schwartz A.R., Smith P.L., Wise R.A., et al. Induction of upper airway occlusion in sleeping individuals with subatmospheric nasal pressure. J Appl Physiol 1988, 64:535.
17. Schwab R.J., Gefter W.B., Pack A.I., Hoffman E.A. Dynamic imaging of the upper airway during respiration in normal subjects. J Appl Physiol 1993, 74:1504.
18. Schwab R.J., Gefter W.B., Hoffman E.A., et al. Dynamic upper airway imaging during respiration in normal subjects and patients with sleep disordered breathing. Am Rev Respir Dis 1993, 148:1385.
19. Schwab R.J., Pack A.I., Gupta K.B., et al. Upper airway and soft tissue structural changes induced by CPAP in normal subjects. Am J Respir Crit Care Med 1996, 154:1106.
20. Morell M.J., Arabi Y., Zahn B., Badr M.S. Progressive retropalatal narrowing preceding obstructive apnea. Am J Respir Crit Care Med 1998, 158:1974.
21. Mahadevia A.K., Onal E., Lopata M. Effects of expiratory positive airway pressure on sleep-induced abnormalities in patients with hypersomnia-sleep apnea syndrome. Am Rev Respir Dis 1983, 128:708.
22. Sanders M.H., Kern N. Obstructive sleep apnea treated by independently adjusted inspiratory and expiratory positive airway pressures via nasal mask: physiologic and clinical implications. Chest 1990, 98:317.
23. Reeves-Hoché M.K., Hudgel D., Meck R., Zwillich C.W. Continuous versus bilevel positive airway pressure for obstructive sleep apnea. Am J Respir Crit Care Med 1995, 151:443.
24. Laursen S.B., Dreijer B., Hemmingsen C., Jaconsen E. Bi-level positive airway pressure treatment of obstructive sleep apnoea syndrome. Respiration 1998, 65:114.
25. Resta O., Guido P., Picca V., et al. Prescription of nCPAP and nBIPAP in obstructive sleep apnoea syndrome: Italian experience in 105 subjects. A prospective two centre study. Respir Med 1998, 92:820.
26. Resta O., Guido P., Picca V., et al. The role of the expiratory phase in obstructive sleep apnoea. Respir Med 1999, 93:190.
27. Schafer H., Hasper E.E., Luderitz B. Failure of CPAP therapy in obstructive sleep apnoea syndrome: predictive factors and treatment with bilevel-positive airway pressure. Respir Med 1998, 92:208.
28. Badr M.S., Toiber F., Skatrud J.B., Dempsey J. Pharyngeal narrowing/occlusion during central sleep apnea. J Appl Physiol 1995, 78:1806.
29. Badr M.S. Effect of ventilatory drive on upper airway patency in humans during NREM sleep. Respir Physiol 1996, 103:1.
30. Morrell M.J., Badr M.S., Harms C.A., Dempsey J.A. The assessment of upper airway patency during apnea using cardiogenic oscillations in the airflow signal. Sleep 1995, 18:651.
31. Baltzan M.A., Kassissia I., Elkoli O., et al. Prevalence of persistent sleep apnea in patients treated with continuous positive airway pressure. Sleep 2006, 29:557.
32. Berry R.B., Parish J.M., Hartse K.M. The use of auto-titrating continuous positive airway pressure for treatment of adult obstructive sleep apnea. Sleep 2002, 25:148.
33. Ayas N.T., Patel S.R., Malhotra A., et al. Auto-titrating versus standard continuous positive airway pressure for the treatment of obstructive sleep apnea: results of a meta-analysis. Sleep 2004, 27:249.
34. Gay P.C., Herold D.L., Olsoen E.J. A randomized, double-blind clinical trial comparing continuous positive airway pressure with a novel bilevel pressure system for treatment of obstructive sleep apnea syndrome. Sleep 2003, 26:864.
35. Nilus G., Happel A., Domanski U., Ruhle K-H. Pressure-relief continuous positive airway pressure vs constant continuous positive airway pressure: a comparison of efficacy and compliance. Chest 2006, 130:1018.
36. Banno K., Okmaura K., Kryger M.H., Dement W.C. Adaptive servo-ventilation in patients with idiopathic Cheyne-Stokes breathing. J Clin Sleep Med 2006, 2:181.
37. Johnson K.G., Johnson D.C. Bilevel positive airway pressure worsens central apneas during sleep. Chest 2005, 128:2141.
38. Teschler H., Dohring J., Wang Y.M., Berthon-Jones M. Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration in heart failure. Am J Respir Crit Care Med 2001, 164:614.
39. Kasai T., Narui K., Dohi T., et al. First experience of using new adaptive servo-ventilation device for Cheyne-Stokes respiration with central sleep apnea among Japanese patients with congestive heart failure. Circ J 2006, 70:1148.
40. Pepperell J.CT., Maskell N.A., Jones D.R., et al. A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure. Am J Respir Crit Care Med 2003, 168:1109.
41. Engleman H.M., Martin S.E., Kingshott R.N., et al. Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome. Thorax 1998, 53:341.
42. Jenkinson C., Davies R.JO., Mullins R., Stradling J.R. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet 1999, 353:2100.
43. Engleman H.M., Douglas N.J. Sleepiness, cognitive function, and quality of life in obstructive sleep apnoea/hypopnoea syndrome. Thorax 2004, 59:618.
44. Marshall N.S., Barnes M., Travier N., et al. Continuous positive airway pressure reduces daytime sleepiness in mild-moderate obstructive sleep apnoea: meta-analysis. Thorax 2006, 61:430.
45. Johns M.W. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991, 14:540.
46. Barnes M., Houston D., Worsnop C.J., et al. A randomized controlled trial of continuous positive airway pressure in mild obstructive sleep apnea. Am J Respir Crit Care Med 2002, 165:773.
47. Monasterio C., Vidal S., Duran J., et al. Effectiveness of continuous positive airway pressure in mild sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 2001, 164:939.
48. Patel S.R., White D.P., Malhotra A., et al. Continuous positive airway pressure for treating sleepiness in a diverse population with obstructive sleep apnea: results of a meta-analysis. Arch Intern Med 2003, 163:565.
49. George C.FP. Driving and automobile crashes in patients with obstructive sleep apnoea/hypopnoea syndrome. Thorax 2004, 59:804.
50. George C.FP., Boudreau A.C., Smiley A. Effects of nasal CPAP on simulated driving performance in patients with obstructive sleep apnoea. Thorax 1997, 52:648.
51. Hack M., Davies R.JO., Mullins R., et al. Randomised prospective parallel trial of therapeutic versus subtherapeutic nasal continuous positive airway pressure on simulated steering performance in patients with obstructive sleep apnoea. Thorax 2000, 55:224.
52. Turkington P.M., Sircar M., Saralaya D., Elliott M.W. Time course of changes in driving simulator performance with and without treatment in patients with sleep apnoea hypopnoea syndrome. Thorax 2004, 59:56.
53. Orth M., Duchna H-W., Leidag M., et al. Driving simulator and neuropsychological testing in OSAS before and under CPAP therapy. Eur Respir J 2005, 26:898.
54. George C.FP. Reduction in motor vehicle collisions following treatment of sleep apnoea with nasal CPAP. Thorax 2001, 56:508-512.
55. Kribbs N.B., Pack A.I., Kline L.R., et al. Effects of one night without nasal CPAP treatment on sleep and sleepiness in patients with obstructive sleep apnea. Am Rev Respir Dis 1993, 147:1162.
56. Lamphere J., Roehrs T., Wittig R., et al. Recovery of alertness after CPAP in apnea. Chest 1989, 96:1364.
57. Philip P., Sagaspe P., Taillard J., et al. Fatigue, sleepiness, and performance in simulated versus real driving conditions. Sleep 2005, 28:1511.
58. Engleman H. Self-reported use of CPAP and benefits of CPAP therapy: a patient survey. Chest 1996, 109:1470.
59. Engleman H.M., Kingshott R.N., Wraith P.K., et al. Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999, 159:461.
60. Kiely J.L., Murphy M., McNicholas W.T. Subjective efficacy of nasal CPAP in obstructive sleep apnoea syndrome: a propsective controlled study. Eur Respir J 1999, 13:1086.
61. Pépin J.L., Leger P., Veale D., et al. Side effects of nasal continuous positive airway pressure in sleep apnea syndrome: study of 193 patients in two French sleep centers. Chest 1995, 107:375.
62. Margel D., Shochat T., Getzler O., et al. Continuous postitive airway pressure reduces nocturia in patients with obstructive sleep apnea. Urology 2006, 67:974.
63. Guilleminault C., Lin C.M., Goncalves M.A., Ramos E. A prospective study of nocturia and the quality of life of elderly with obstructive sleep apnea or sleep onset insomnia. J Psychosom Res 2004, 56:511.
64. Fitzgerald M.P., Mulligan M., Parthasarathy S. Nocturic frequency is related to severity of obstructive sleep apnea, improves with continuous positive airways treatment. Am J Obstet Gynecol 2006, 194:1399.
65. Russo-Magno P., O'Brien A., Panciera T., Rounds S. Compliance with CPAP therapy in older men with obstructive sleep apnea. J Am Geriatr Soc 2001, 49:1205.
66. McFadyen T.A., Espie C.A., McArdle N., et al. Controlled, prospective trial of psychosocial function before and after continuous positive airway pressure therapy. Eur Respir J 2001, 18:996.
67. Ballester E., Badia J.R., Hernandez L., et al. Evidence of the effectiveness of continuous positive airway pressure in the treatment of sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999, 159:495.
68. Zimmerman M.E., Arnedt J.T., Stanchina M., et al. Normalization of memory performance and positive airway pressure in memory-impaired patients with obstructive sleep apnea. Chest 2006, 130:1772.
69. Engleman H.M., Martin S.E., Deary I.J., Douglas N.J. Effect of continuous positive airway pressure treatment on daytime function in sleep apnea/hypopnea syndrome. Lancet 1994, 343:572.
70. Meurice J-C., Dore P., Paquereau J., et al. Predictive factors of long-term compliance with nasal continuous positive airway pressure treatment in sleep apnea syndrome. Chest 1994, 105:429.
71. Hoffstein V., Viner S., Mateika S., Conway J. Treatment of obstructive sleep apnea with nasal continuous positive airway pressure: patient compliance, perception of benefits, and side effects. Am Rev Respir Dis 1992, 145:841.
72. Kribbs N.B., Pack A.I., Kline L.R., et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis 1993, 147:887.
73. Fletcher E.C., Luckett R.A. The effect of positive reinforcement on hourly compliance in continuous positive airway pressure users with obstructive sleep apnea. Am Rev Respir Dis 1991, 143:936.
74. Waldhorn R.E., Herrick T.W., Nguyen M.C., et al. Long-term compliance with nasal continuous positive airway pressure therapy of obstructive sleep apnea. Chest 1990, 97:33.
75. Richards G.N., Cistulli P.A., Ungar R.G., et al. Mouth leak with nasal continuous positive airway pressure increases nasal airway resistance. Am J Respir Crit Care Med 1996, 154:182.
76. Nino-Murcia G., McCann C.C., Bliwise D.L., et al. Compliance and side effects in sleep apnea patients treated with continuous positive airway pressure. West J Med 1989, 150:165.
77. Alvarez-Sala R., Garcia I.T., Garcia F., et al. Nasal CPAP during wakefulness increases intraocular pressure in glaucoma. Monaldi Arch Chest Dis 1994, 49:394.
78. Alvarez-Sala R., Diaz S., Prados C., et al. Increase of intraocular pressure during nasal CPAP. Chest 1992, 101:1477.
79. Weaver T.E., Mailslin G., Dinges D.F., et al. Self-efficacy in sleep apnea: instrument development and patient perceptions of obstructive sleep apnea risk, treatment benefit, and volition to use continuous positive airway pressure. Sleep 2003, 26:727.
80. Chasens E.R., Pack A.I., Maislin G., et al. Claustrophobia and adherence to CPAP treatment. West J Nurs Res 2005, 27:307.
81. Stepnowsky C.J., Bardwell W.A., Moore P.J., et al. Psychologic correlates of compliance with continuous positive airway pressure. Sleep 2002, 25:758.
82. Stepnowsky C.J., Marler M.R., Ancoli-Israel S. Determinants of nasal CPAP compliance. Sleep Med 2002, 3:239.
83. McArdle N., Devereux G., Heidarneid H., et al. Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999, 159:1108.
84. Edinger J.D., Radtke R.A. Use of in vivo desensitization to treat a patient's claustrophobic response to nasal CPAP. Sleep 1993, 16:678.
85. Prosise G.L., Berry R.B. Oral-nasal continuous positive airway pressure as a treatment for obstructive sleep apnea. Chest 1994, 106:180.
86. Sanders M.H., Kern N.B., Stiller R.A. Use of an oro-nasal interface in the positive pressure therapy of sleep apnea. Chest 1994, 106:774.
87. Mortimore I.L., Whittle A.T., Douglas N.J. Comparison of nose and face mask CPAP therapy for sleep apnoea. Thorax 1998, 53:290.
88. Likar L.L., Panciera T.M., Erickson A.D., Rounds S. Group education sessions and compliance with nasal CPAP therapy. Chest 1997, 111:1273.
89. Stauffer J.L., Fayter N.A., McClure B.J. Conjunctivitis from nasal CPAP apparatus. Chest 1984, 86:802.
90. Massie C.A., Hart R.W. Clinical outcomes related to interface type in patients with obstructive pressure sleep apnea/hypopnea syndrome who are using continuous positive airway pressure. Chest 2003, 123:1112.
91. Fleury B., Barros V.S., Rakotonanahary D., et al. Comparison of cold passover versus heated humidification during nCPAP therapy. Am J Respir Crit Care Med 1997, 155:A304.
92. Duong M., Jayaram L., Camfferman D., et al. Use of heated humidification during nasal CPAP titration in obstructive sleep apnoea. Eur Respir J 2005, 26:679.
93. Massie C.A., Hart R.W., Peralez K., Richards G.N. Effects of humidification on nasal symptoms and compliance in sleep apnea patients using continuous positive airway pressure. Chest 1999, 116:4703.
94. Mador M.J., Krauza M., Pervez A., et al. Effect of heated humidification on compliance and quality of life in patients with sleep apnea using nasal continuous positive airway pressure. Chest 2005, 128:2151.
95. Neill A.M., Wai H.S., Bannan S.PT., et al. Humidified nasal continuous positive airway pressure in obstructive sleep apnoea. Eur Respir J 2003, 22:258.
96. Rakotonanahary D., Pelletier-Fleury N., Gagnadoux F., Fleury B., et al. Predictive factors for the need for additional humidification during nasal continuous positive airway pressure therapy. Chest 2001, 119:460.
97. Brown L.K. Back to Basics. If it's dry, wet it: the case for humidification of nasal continuous positive airway pressure air. Chest 2000, 117:617.
98. Weaver T.E., Kribbs N.B., Pack A.I., et al. Night-to-night variability in CPAP use over the first three months of treatment. Sleep 1997, 20:278.
99. Strumpf D.A., Harrop P., Dobbin J., et al. Massive epistaxis from nasal CPAP therapy. Chest 1989, 95:1141.
100. Kuzniar T.J., Gruber B., Mutlu G.M. Cerebrospinal fluid leak and meningitis associated with nasal continuous positive airway pressure therapy. Chest 2005, 128:1882.
101. Jarjour N.N., Wilson P. Pneumoencephalus associated with nasal continuous positive airway pressure in a patient with sleep apnea syndrome. Chest 1989, 96:1425.
102. Bernstein A.L., Cassidy J., Duchynski R., Eisenberg S.S. Atypical headache after prolonged treatment with nasal continuous positive airway pressure. Headache 2005, 45:609.
103. Sanders M.H., Moore S.E., Evaslage J. CPAP via nasal mask: a treatment for occlusive sleep apnea. Chest 1983, 83:144.
104. Grunstein R.R. Continuous positive airway pressure treatment for obstructive sleep apnea-hypopnea syndrome. Principles and Practice of Sleep Medicine 2005, 1066. Elsevier Saunders, Philadelphia. 4th ed. M.H. Kryger, T. Roth, W.C. Dement (Eds.).
105. Alex C.G., Aronson R.M., Onal E., et al. Effects of continuous positive airway pressure on upper airway and respiratory muscle activity. J Appl Physiol 1987, 62:2026.
106. Kushida C.A., Littner M.R., Hirshkowitz M., et al. Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders. Sleep 2006, 29:375.
107. Krieger J., Weitzenblum E., Monassier J-P., et al. Dangerous hypoxaemia during continuous positive airway pressure treatment of obstructive sleep apnoea. Lancet 1983, 2:1429.
108. 2 and CPAP in obstructive sleep apnea (OSA) patients. Am Rev Respir Dis 1993, 147:A681.
109. 2 during non-REM and REM sleep in patients with obstructive sleep apnea syndrome. Sleep 1993, 16(Suppl):S144.
110. Piper A.J., Sullivan C.E. Effects of short-term NIPPV in the treatment of patients with severe obstructive sleep apnea and hypercapnia. Chest 1994, 105:434.
111. Rapoport D.M., Sorkin B., Garay S.M., et al. Reversal of the "pickwickian syndrome" by long-term use of nocturnal airway pressure. N Engl J Med 1982, 307:931.
112. Sullivan C.E., Berthon-Jones M., Eves L., Issa F.G. Remission of severe obesity-hypoventilation syndrome after short term treatment during sleep with nasal continuous positive airway pressure. Am Rev Respir Dis 1982, 128:177.
113. Shivarum U., Cash M.E., Beal A. Nasal continuous positive airway pressure in decompensated hypercapnic respiratory failure as a complication of sleep apnea. Chest 1993, 104:770.
114. Arias M.A., Garcia-Rio F., Alonso-Fernandez A., et al. Pulmonary hypeertension in obstuctive sleep apnoea: a randomized, controlled cross-over study. Eur Heart J 2006, 27:1106.
115. 2 drive in patients with obstructive sleep apnea and effect of CPAP. Respir Physiol 1995, 101:279.
116. 2 with long-term CPAP therapy for obstructive sleep apnea. Am Rev Respir Dis 1987, 135:144.
117. Mateika J.H., Ellythy M. Chemoreflex control of ventilation is altered during wakefulness in humans with OSA. Respir Physiol Neurobiol 2003, 138:45.
118. White D.P., Douglas N.J., Pickett C.K., et al. Sleep deprivation and the control of ventilation. Am Rev Respir Dis 1983, 128:984.
119. Spengler C.M., Shea S.A. Sleep deprivation per se does not decrease the hypercapnic ventilatory response in humans. Am J Respir Crit Care Med 1999, 161:1124.
120. Campos-Rodriguez F., Pena-Grinan N., Reyes-Nunez N., et al. Mortality in obstructive sleep apnea-hypopnea patients treated with positive airway pressure. Chest 2005, 128:624.
121. Sforza E., Lugaresi E. Daytime sleepiness and nasal continuous positive airway pressure in obstructive sleep apnea patients: effects of chronic treatment and 1 night therapy withdrawal. Sleep 1995, 18:195.
122. Fleury B., Rakotonanahary D., Tehindrazanarivelo A.D., et al. Long term compliance to continuous positive airway pressure therapy (nCPAP) set up during a split-night polysomnography. Sleep 1994, 17:512.
123. Rauscher H., Popp W., Wanke T., Zwick H. Acceptance of CPAP therapy for sleep apnea. Chest 1991, 100:1019.
124. Krieger J. Long-term compliance with nasal continuous positive airway pressure (CPAP) in obstructive sleep apnea patients and nonapneic snorers. Sleep 1992, 15:S42.
125. Reeves-Hoché M.K., Meck R., Zwillich C.W. Nasal CPAP: an objective evaluation of patient compliance. Am J Respir Crit Care Med 1994, 149:149.
126. Strollo P.J., Sanders M.H., Costantino J.P., et al. Split night polysomnography does not affect compliance with positive pressure via a mask in the treatment of patients with obstructive sleep apnea. Sleep 1996, 19:255.
127. Sanders M.H., Costantino J.P., Strollo P.J., et al. The impact of split-night polysomnography for diagnosis and positive pressure therapy titration on treatment acceptance and adherence in sleep apnea/hypopnea. Sleep 2000, 23:17.
128. Iber C., O'Brien C., Schluter J., et al. Single night studies in obstructive apnea. Sleep 1991, 14:383.
129. Sanders M.H., Black J., Costantino J.P., et al. Diagnosis of sleep-disordered breathing by half-night polysomnography. Am Rev Respir Dis 1991, 144:1256.
130. Sanders M.H., Kern N.B., Costantino J., et al. Adequacy of prescribing positive airway pressure therapy by mask for sleep apnea on the basis of a partial-night trial. Am Rev Respir Dis 1993, 147:1169.
131. Yamashiro Y., Kryger M.H. CPAP titration for sleep apnea using a split-night protocol. Chest 1995, 107:62.
132. McArdle N., Grove A., Devereux G., et al. Split-night versus full-night studies for sleep apnoea/hypopnoea syndrome. Eur Respir J 2000, 15:670.
133. Gay P., Weaver T., Loube D., Iber C. Evaluation of positive airway pressure treatment for sleep related breathing disorders in adults: a review of the Positive Airway Pressure Task Force of the Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep 2006, 29:381.
134. Kushida C.A., Littner M.R., Morgenthaler T.I., et al. Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep 2005, 28:499.
135. Pepin J.L., Leger P., Veale D., et al. Side effects of nasal continuous positive airway pressure in sleep apnea syndrome: study of 193 patients in two French sleep centers. Chest 1995, 107:375.
136. Hers V., Listro G., Dury M., et al. Residual effect of nCPAP applied to part of the night in patient with obstructuve sleep apnoeas. Eur Respir J 1997, 10:973.
137. Sériès F., Roy N., Marc I. Effects of sleep deprivation and sleep fragmentation on upper airway collapsibility in normal subjects. Am J Respir Crit Care Med 1994, 150:481.
138. McNicholas W.T. Compliance with nasal CPAP therapy for obstructive sleep apnoea: how much is enough?. Eur Respir J 1997, 10:969.
139. Pelletier-Fleury N., Rakotonanahary D., Fleury B. The age and other factors in the evaluation of compliance with nasal continuous positive airway pressure for obstructive sleep apnea syndrome: a Cox's proportional hazard analysis. Sleep Med 2001, 2:225.
140. Collard P., Pieters T., Aubert G., et al. Compliance with nasal CPAP in obstructive sleep apnea patients. Sleep Med Rev 1997, 1:33.
141. Engleman H.M., Martin S.E., Douglas N.J. Compliance with CPAP therapy in patients with the sleep apnoea/hypopnea syndrome. Thorax 1994, 49:263.
142. Fletcher E.C. The relationship between systemic hypertension and obstructive sleep apnea: facts and theory. Am J Med 1995, 98:118.
143. Engleman H.M., Douglas N.J. CPAP compliance. Sleep 1993, 16:S114.
144. Chervin R.D., Theut S., Bassetti C., Aldrich M.S. Compliance with nasal CPAP can be improved by simple interventions. Sleep 1997, 20:284.
145. Anderson F.E., Kingshott R.N., Taylor D.R., et al. A randomized crossover efficacy trial of oral CPAP (Oracle) compared with nasal CPAP in the management of obstructive sleep apnea. Sleep 2003, 26:721.
146. Pressman M.R., Peterson D.D., Meyer T.J., et al. Ramp abuse: a novel form of patient noncompliance to administration of nasal continuous positive airway presssure treatment of obstructive sleep apnea. Am J Respir Crit Care Med 1995, 151:1632.
147. Aloia M.S., Stanchina M., Arnedt J.T., et al. Treatment adherence and outcomes in flexible vs standard continuous positive airway pressure therapy. Chest 2005, 127:2085.
148. Nilius G., Happel A., Domanski U., Ruhle K-H. Pressure-relief continuous positive airway pressure vs continuous positive airway pressure. Chest 2006, 130:1018.
149. Ballard R.D., Gay P.G., Strollo P.J. Intervention to improve compliance in sleep apnea patients previously non-compliant with continuous positive airway pressure. J Clin Sleep Med 2007, 3:706.
150. Weaver T.E., Chugh D.K., Maislin G., et al. Comparison of CPAP nightly duration to nocturnal sleep time. Am J Respir Crit Care Med 1997, 155:A304.
151. Hoy C.J., Vennelle M., Douglas N.J. Can CPAP use be improved?. Am J Respir Crit Care Med 1997, 155:A304.
152. Hui D.SC., Chan J.KW., Choy D.KL., et al. Effects of augmented continuous positive airway pressure education and support on compliance and outcome in a Chinese population. Chest 2000, 117:1410.
153. Dekker F.W., Dieleman F.E., Kaptein A.A., Mulder J.D. Compliance with pulmonary medication in general practice. Eur Respir J 1993, 6:886.
154. Fry J.M., DiPhillipo M.A., Pressman M.R. Periodic leg movements in sleep following treatment of obstructive sleep apnea with nasal continuous positive airway pressure. Chest 1989, 96:89.
155. Yamashiro Y., Kryger M.H. Acute effect of nasal CPAP on periodic limb movements associated with breathing disorders during sleep. Sleep 1994, 17:172.
156. Carelli G., Krieger J., Calvi-Gries F., Macher J.P. Periodic limb movements and obstructive sleep apneas before and after continuous positive airway pressure treatment. J Sleep Res 1999, 8:211.
157. Flemons W.W., Douglas N.J., Kuna S.T., et al. Access to diagnosis and treatment of patients with suspected sleep apnea. Am J Respir Crit Care Med 2004, 169:668.
158. Deutsch P.A., Simmons M.S., Wallace J.M. Cost-effectiveness of split-night polysomnography and home studies in the evaluation of obstructive sleep apnea syndrome. J Clin Sleep Med 2006, 2:145.
159. Kapur V.K., Sullivan S.D. More isn't always better: cost-effectiveness analysis and the case for using a split-night protocol. J Clin Sleep Med 2006, 2:154.
160. Elshaug A.G., Moss J.R., Southcott A.M. Implementation of a split night protocol to improve efficiency in assessment and treatment of obstructive sleep apnoea. Intern Med J 2005, 35:251.
161. Coppola M.P., Lawee M. Management of obstructive sleep apnea syndrome in the home: the role of portable sleep apnea recording. Chest 1993, 104:19.
162. Waldhorn R.E., Wood K. Attended home titration of nasal continuous positive airway pressure therapy for obstructive sleep apnea. Chest 1993, 104:1707.
163. Miljeteig H., Hoffstein V. Determinants of continuous positive airway pressure level for treatment of obstructive sleep apnea. Am Rev Respir Dis 1993, 147:1526.
164. Hoffstein V., Mateika S. Predicting nasal continuous positive airway pressure. Am J Respir Crit Care Med 1994, 150:486.
165. Hukins C.A. Arbitrary-pressure continuous positive airway pressure for obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2005, 171:500.
166. Bao G., Guilleminault C. Upper airway resistance syndromeone decade later. Curr Opinion Pulm Med 2004, 10:461.
167. Fitzpatrick M.F., Alloway C.ED., Wakeford T.M., et al. Can patients with obstructive sleep apnea titrate their own continuous positive airway pressure?. Am J Respir Crit Care Med 2003, 167:716-722.
168. Masa J.F., Jimenez A., Duran J., et al. Alternative methods of titrating continuous positive airway pressure: a large multicenter study. Am J Respir Crit Care Med 2004, 170:1218.
169. West S.D., Jones D.R., Stradling J.R. Comparison of three ways to determine and deliver pressure during nasal CPAP therapy for obstructive sleep apnoea. Thorax 2006, 61:226.
170. Marin J.M., Carrizo S.J., Vicente E., Agusti A.GN. Long-term cardiovascular outcomes in men with obstructive sleep apnoea hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005, 365:1046.
171. Marti S., Sampol G., Munoz X., et al. Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment. Eur Respir J 2002, 20:1511.
172. Peker Y., Hedner J., Norum J., et al. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med 2002, 166:159.
173. Bradley T.D., Logan A.G., Kimoff R.J., et al. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 2005, 353:2025. for the CANPAP Investigators.
174. Guilleminault C., Connolly S.J., Winkle R.A. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 1983, 5:490.
175. Mooe T., Gullsby S., Rabben T., Eriksson P. Sleep-disordered breathing: a novel predictor of atrial fibrillation after coronary artery bypass surgery. Coron Artery Dis 1996, 7:475.
176. Becker H.F., Koehler U., Stammnitz A., Peter J.H. Heart block in patients with sleep apnoea. Thorax 1998, 53(Suppl):S29.
177. Koehler U., Fus E., Grimm W. Heart block in patients with obstructive sleep apnoea: pathogenetic factors and effects of treatment. Eur Respir J 1998, 11:434.
178. Simantirakis E.N., Schizab S.I., Marketoua M.E., et al. Severe bradyarrhythmias in patients with sleep apnoea: the effect of continuous positive airway pressure treatment. A long-term evaluation using an insertable loop recorder. Eur Heart J 2004, 25:1070.
179. Gami A.S., Pressman G., Caples S.M., et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation 2004, 110:364.
180. Alonso-Fernández A., García-Río F., Racionero M.A., et al. Cardiac rhythm disturbances and ST-segment depression episodes in patients with obstructive sleep apnea-hypopnea syndrome and its mechanisms. Chest 2005, 127:15.
181. Mehra R., Benjamin E.J., Shahar E., et al. Association of nocturnal arrhythmias with sleep-disordered breathing: the Sleep Heart Health Study. Am J Respir Crit Care Med 2006, 173:910.
182. Browne K.F., Prystowsky E., Heger J.J., et al. Prolongation of the QT interval in man during sleep. Am J Cardiol 1983, 52:55.
183. Gillis A.M., MacLean K.E., Guilleminault C. The QT interval during wake and sleep in patients with ventricular arrhythmias. Sleep 1988, 11:333.
184. Gillis A.M., Stoohs R., Guilleminault C. Changes in the QT interval during obstructive sleep apnea. Sleep 1991, 14:346.
185. Sato F., Nishimura M., Shinano H., et al. Heart rate during obstructive sleep apnea depends on individual hypoxic chemosensitivity of the carotid body. Circulation 1997, 96:274.
186. Dursunoglu D., Dursunoglu N., Evrengul H., et al. QT interval dispersion in obstructive sleep apnoea syndrome patients without hypertension. Eur Respir J 2005, 25:677.
187. Becker H., Brandenburg U., Peter J. Reversal of sinus arrest and atrioventricular conduction block in patients with sleep apnea during nasal continuous positive airway pressure. Am J Respir Crit Care Med 1995, 151:215.
188. Gami A.S., Friedman P., Chung M.K., et al. Therapy Insight: interactions between atrial fibrillation and obstructive sleep apnea. Nat Clin Pract Cardiovasc Med 2005, 2:145.
189. Ryan C.M., Usui K., Floras J.S., Bradley T.D. Effect of continuous positive airway pressure on ventricular ectopy in heart failure patients with obstructive sleep apnoea. Thorax 2005, 60:781.
190. Marrone O., Riccobono L., Salvaggio A., et al. Catecholamines and blood pressure in obstructive sleep apnea syndrome. Chest 1993, 103:722.
191. Tkacova R., Rankin F., Fitzgerald F.S., et al. Effects of continuous positive airway pressure on obstructive sleep apnea and left ventricular afterload in patients with heart failure. Circulation 1998, 98:2269.
192. Malone S., Liu P.P., Holloway R., et al. Obstructive sleep apnoea in patients with dilated cardiomyopathy: effects of continuous positive
193. Kaneko Y., Floras J.S., Usui K., et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003, 348:1233.
194. Mansfield D.R., Gollogly N.C., Kaye D.M., et al. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am Rev Respir Crit Care Med 2004, 169:361.
195. Narkiewicz K., Kato M., Phillips B.G., et al. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 1999, 100:2332.
196. Tolle F.A., Judy W.V., Yu P-L., Markand O.N. Reduced stroke volume related to pleural pressure in obstructive sleep apnea. J Appl Physiol 1983, 336:1718.
197. Pankow W., Nabe B., Lies A., et al. Influence of sleep apnea on 24-hour blood pressure. Chest 1997, 112:1253.
198. Davies C.WH., Crosby J.H., Mullins R.L., et al. Case-control study of 24 hour ambulatory blood pressure in patients with obstructive sleep apnoea and normal matched control subjects. Thorax 2000, 55:736.
199. Lavie P., Herer P., Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 2000, 320:479.
200. Nieto F.J., Young T.B., Lind B.K., et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000, 283:1829.
201. Bixler E.O., Vgontzas A.N., Lin H.M., et al. Association of hypertension and sleep-disordered breathing. Arch Intern Med 2000, 160:2289.
202. Peppard P.E., Young T., Palta M., Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000, 342:1378.
203. Pepperell J.CT., Davies R.JO., Stradling J.R. Systemic hypertension and obstructive sleep apnoea. Sleep Med Rev 2002, 6:157.
204. Chobanion A.V., Bakris G.L., Black H.R., et al. 7th Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003, 289:2560. for the National High Blood Pressure Program Coordinating Committee, U.S. Department of Health and Human Services, and National Heart, Lung, and Blood Institute, National Institutes of Health.
205. Fletcher E.C., Lesske J., Qian W., et al. Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats. Hypertension 1992, 19:555.
206. Waravdekar N.V., Sinoway L.I., Zwillich C.W., Leuenberger U.A. Influence of treatment on muscle sympathetic nerve activity in sleep apnea. Am J Respir Crit Care Med 1996, 153:1333.
207. Brooks D., Horner R.L., Kozar L.F., et al. Obstructive sleep apnea as a cause of systemic hypertension: evidence from a canine model. J Clin Invest 1997, 99:106.
208. Sica A.L., Greenberg H.E., Ruggiero D.A., Scharf S.M. Chronic-intermittent hypoxia: a model of sympathetic activation in the rat. Respir Physiol 2000, 121:173.
209. Bao G., Metreveli N., Li R., et al. Blood pressure response to chronic episodic hypoxia: role of the sympathetic nervous system. J Appl Physiol 1997, 83:95.
210. Morrell M.J., Finn L., Kim H., et al. Sleep fragmentation, awake blood pressure, and sleep-disordered breathing in a population-based study. Am J Respir Crit Care Med 2000, 162:2091.
211. Belozeroff V., Berry R.B., Sassoon C.SH., Khoo M.CK. Effects of CPAP therapy on cardiovascular variability in obstructive sleep apnea: a closed-loop analysis. Am J Physiol Heart Circ Physiol 2002, 282:H110.
212. Mills P.J., Kennedy B.P., Loredo J.S., et al. Effects of nasal continuous positive airway pressure and oxygen supplementation on norepinephrine kinetics and cardiovascular responses in obstructive sleep apnea. J Appl Physiol 2006, 100:343.
213. Bonsignore M.R., Parati G., Insalaco G., et al. Baroreflex control of heart rate during sleep in severe obstructive sleep apnoea: effects of acute CPAP. Eur Respir J 2006, 27:128.
214. Pepperell J.CT., Ramdassingh-Dow S., Crosthwaite N., et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002, 359:204.
215. Arzt M., Flores J.S., Logan A.G., et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post-hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Apnea and Heart Failure Trial (CANPAP). Circulation 2007, 115:3173. for the CANPAP Investigators.
216. Becker H.F., Jerrentrup A., Ploch T., et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003, 107:68.
217. Barbe F., Mayoralas L.R., Duran J., et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. Ann Intern Med 2001, 134:1015.
218. Campos-Rodriguez F., Grilo-Reina A., Perez-Ronchel J., et al. Effect of continuous positive airway pressure on ambulatory BP in patients with sleep apnea and hypertension: a placebo-controlled trial. Chest 2006, 129:1459.
219. Robinson G.V., Smith D.M., Langford B.A., et al. Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients. Eur Respir J 2006, 27:1229.
220. Logan A.G., Tkacova R., Perlikowski S.M., et al. Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex. Eur Respir J 2003, 21:241.
221. Arzt M., Young T., Finn L., et al. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 2005, 172:1447.
222. Turkington P.M., Allgar V., Bamford J., et al. Effect of upper airway obstruction in acute stroke on functional outcome at 6 months. Thorax 2004, 59:367.
223. Gibson G.J. Sleep disordered breathing and the outcome of stroke. Thorax 2004, 59:361.
224. Parra O., Arboix A., Montserrat J.M., et al. Sleep-related breathing disorders: impact on mortality of cerebrovascular disease. Eur Respir J 2004, 24:267.
225. Yaggi H.K., Concato J., Kernan W.N., et al. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005, 353:2034.
226. Dziewas R., Humpert M., Hopmann B., et al. Increased prevalence of sleep apnea in patients with recurring ischemic stroke compared with first stroke victims. J Neurol 2005, 252:1394.
227. Bassetti C.L., Milanova M., Gugger M. Sleep-disordered breathing and acute ischemic stroke: diagnosis, risk factors, treatment, evolution, and long-term clinical outcome. Stroke 2006, 37:967.
228. Martinez-Garcia M.A., Galiano-Blancart R., Roman-Sanchez P., et al. Continuous positive airway pressure treatment in sleep apnea prevents new vascular events after ischemic stroke. Chest 2005, 128:2123.
229. Hsu C-Y., Vennelle M., Li H-Y., et al. Sleep-disordered breathing after stroke: a randomised controlled trial of continuous positive airway pressure. J Neurol Neurosurg Psychiatry 2006, 77:1143.
230. Sandberg O., Franklin K.A., Bucht G., et al. Nasal continuous positive airway pressure in stroke patients with sleep apnoea: a randomized treatment study. Eur Respir J 2001, 18:630.
231. Punjabi N.M., Sorkin J.D., Katzel L.I., et al. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 2002, 165:677.
232. Meslier N., Gagnadoux F., Giraud P.C., et al. Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome. Eur Respir J 2003, 22:156.
233. Elmasry A., Lindberg E., Berne C., et al. Sleep-disordered breathing and glucose metabolism in hypertensive men: a population-based study. J Intern Med 2001, 249:153.
234. Ip M.SM., Lam B., Ng M.MT., et al. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002, 165:670.
235. Punjabi N.M., Ahmed M.M., Polotsky V.Y., et al. Sleep-disordered breathing, glucose intolerance, and insulin resistance. Respir Physiol Neurobiol 2003, 136:167.
236. Punjabi N.M., Polotsky V.Y. Disorders of glucose metabolism in sleep apnea. J Appl Physiol 2005, 99:1998.
237. Punjabi N.M., Shahar E., Redline S., et al. Sleep-disordered breathing, glucose intolerance, and insulin resistance. The Sleep Heart Health Study. Am J Epidemiol 2004, 160:521. Sleep Heart Health Study Investigators.
238. Reichmuth K.J., Austin D., Skatrud J.B., Young T. Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med 2005, 172:1590.
239. Brooks B., Cistulli P.A., Borkman M., et al. Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness. J Clin Endocrinol Metab 1994, 79:1684.
240. Harsch I.A., Schahin S.P., Radespiel-Tröger M., et al. CPAP Treatment rapidly improves insulin sensitivity in patients with OSAS. Am J Respir Crit Care Med 2004, 169:156.
241. Babu A.R., Herdegen J., Fogelfeld L., et al. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med 2005, 165:447.
242. 1c in men with obstructive sleep apnoea and type 2 diabetes. Thorax 2007, 62:969.